A novel in-vitro diagnostic test for drug-resistant tuberculosis and a personalized antibiotic treatment plan.

Project Information

Tuberculini

Grant agreement ID: 877807

DOI 10.3030/877807

Project closed

EC signature date 18 July 2019

Start date 1 August 2019

End date 31 January 2020

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

CLEMEDI AG
Switzerland